PharmaCorp Rx

PharmaCorp Rx Piotroski F-Score

The Piotroski F-Score of PharmaCorp Rx (PCRX.V) as of Oct 25, 2026 is 6. In the previous year, Piotroski F-Score was 5.00 — a change of 20.00% (higher).

Piotroski F-Score

6

YoY

20.00%

Last updated:

Piotroski F-Score of PharmaCorp Rx is 2025 6 . Piotroski F-Score of PharmaCorp Rx was 2024 5.00 . It decreases by 20.00% higher compared to the previous year.

The PharmaCorp Rx Piotroski F-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Piotroski F-Score
Date
Piotroski F-Score
Jan 1, 2022
2.00 CAD
Jan 1, 2023
1.00 CAD
Jan 1, 2024
5.00 CAD
Jan 1, 2025
6.00 CAD
The PharmaCorp Rx Piotroski F-Score history
YEARPiotroski F-ScoreYoY
6+20.00%
5+400.00%
1-50.00%
2—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PharmaCorp Rx Stock analysis

What does PharmaCorp Rx do? Proton Capital Corp. identifies and evaluates potential assets or businesses for a qualifying transaction. The company has not selected a specific sector or industry for its future operations. It has no commercial operations and no assets as of now. The firm is structured as a capital pool company aiming to complete a qualifying transaction in the future. The company's primary focus is on identifying and evaluating assets or businesses without specifying a target sector. It has not commenced commercial operations and has no assets. Proton Capital Corp. operates as a capital pool company with the intention of completing a qualifying transaction in the future. Proton Capital Corp. has not selected a business sector or industry for its qualifying transaction. The firm remains in a pre-commercial phase with no assets or operations. It is structured as a capital pool company that will seek to complete a qualifying transaction once a suitable target is identified. PharmaCorp Rx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaCorp Rx stock

Piotroski F-Score of PharmaCorp Rx is 6 in 2025.

On Eulerpool you can find the complete historical development of Piotroski F-Score PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

The Piotroski F-Score rates a company from 0-9 based on profitability, leverage, liquidity, and operating efficiency. Scores of 8-9 indicate strong fundamentals.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — PharmaCorp Rx

All Key Metrics — PharmaCorp Rx